TrialHeadache2021

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction study.

Abhijeet Jakate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.